Maintenance chemotherapy has a long history of use in hematologic malignancies, in which
the benefits are considerable in terms of survival and quality of life. Recently, several studies …

Introduction: The concept of maintenance therapy in lung cancer has stirred a great deal of
interest over the last decade. Several randomized studies have been conducted to find out …

Recent trials have shown a benefit with maintenance therapy after 4 to 6 cycles of
chemotherapy. These trials have shown improvement in progression-free survival using …

Introduction: Several randomized trials on maintenance therapy (MT) for metastatic non–
small-cell lung cancer (NSCLC) have demonstrated benefit in progression-free survival …

Lung cancer is the most common cancer worldwide with non-small cell lung cancer
(NSCLC), including squamous carcinoma, adenocarcinoma and large cell carcinoma …

Although well established for the treatment of certain hematologic malignancies,
maintenance therapy has only recently become a treatment paradigm for advanced non …

Metastatic non-small cell lung cancer remains a disease with a high annual incidence and
annual mortality worldwide, with limitations in first-line treatment past a fixed amount of …

Maintenance therapy for patients with advanced non-small cell lung cancer has been an
area of intense investigation. Maintenance therapy has been divided into two broad …

Systemic chemotherapy with platinum‐based regimens provides modest improvements in
survival and quality of life for patients with advanced‐stage nonsmall‐cell lung cancer …

Maintenance treatment has been intensively investigated in the field of advanced/metastatic
non-small lung cancer in order to improve outcomes in this devastating disease. Two …